Trial intelligence / Profile preview

Vasopressin versus placebo in hysteroscopic myomectomy

ChiCTR-TRC-11001784Phase 4Completed

Sponsor
North District Hospital
Start
Dec 2011
Modality
Peptides
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in Fibromyoma (LM) comparing Vasopressin with Placebo (2 arms). Primary endpoints: Surgical time and Fluid difference. Started Dec 2011; status: completed.

02

Drugs

vasopressin
03

Conditions

Fibromyoma (LM)

Beyond the preview

Go deeper on ChiCTR-TRC-11001784.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-11001784.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call